Leidos Hld

Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company's customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on June 1, 1969, and is headquartered in Reston, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Leidos reports record revenue and EPS, poised for growth

Leidos' strong financial performance, strategic investments, and talent acquisition position the company for continued growth and competitive advantage.
While challenges in optimizing operational efficiency and managing costs exist, opportunities in technology adoption, program expansions, and strategic partnerships offer avenues for future growth.
Roger Krone's proactive responses to inquiries demonstrate Leidos' readiness for various scenarios and commitment to driving shareholder value through strategic decision-making.

Leidos reports record revenues, focuses on growth and efficiency

Leidos delivered strong revenue growth in Q1 2023, with a focus on resolving operational challenges and improving margins.
The company's strategic hiring, capital allocation, and customer-centric approach position it well for future growth.
Despite challenges in certain segments, Leidos remains optimistic about its outlook and is committed to driving performance improvements.

Leidos posts robust Q2 results, eyes margin expansion and growth

Leidos reported strong financial results for Q2 2023, with revenue growth, margin improvement, and increased earnings. The company is investing in talent and technology innovation while focusing on strategic enhancements and margin opportunities. Challenges include market dynamics and the DHMSM wind-down impact, but Leidos is optimistic about its growth trajectory.

Leidos reports record Q3 results, raises guidance amid strategic initiatives

Leidos' exceptional Q3 performance, record revenue, and raised guidance underscore its financial strength and strategic positioning for growth.
While facing challenges from market changes and potential government shutdown risks, the company's strong fundamentals and initiatives provide resilience.
Opportunities lie in continued performance incentives, sector-specific growth strategies, and efficiency enhancements through organizational realignment.
Overall, Leidos' focus on profitability, margin expansion, and operational excellence sets a positive trajectory for future success and shareholder value.

Leidos reports robust Q4 earnings, eyes international growth opportunities

Leidos (LDOS) delivered strong financial results in Q4 2023, exceeding guidance and demonstrating operational efficiency and strategic focus.
While facing challenges like budget uncertainties and potential regulatory changes, the company remains poised for growth and profitability in 2024.
With a commitment to shareholder value, talent retention, and market expansion, Leidos is well-positioned to capitalize on international opportunities and technological advancements.
Strategic investments in key sectors and ongoing operational enhancements signal a resilient and forward-thinking approach to navigating market dynamics and driving sustainable growth.

Leidos reports robust Q1 performance, eyes growth in disruptive tech

Leidos delivered impressive financial results in Q1 2024, with strong revenue growth and margin improvement. The company's strategic focus on disruptive technologies, global expansion, and disciplined capital management underscores its commitment to sustainable growth and shareholder value.

Leidos achieves record quarter, raises guidance on strong performance

Leidos reported exceptional financial performance, demonstrating strong growth, profitability, and strategic investments. The company's focus on innovation, acquisitions, and operational efficiency positions it well for future success. While challenges exist, Leidos is capitalizing on opportunities in emerging technology sectors and strategic acquisitions to drive continued growth and value creation.

Leidos Hld (LDOS) posts record margins and earnings growth in Q3 2024

Leidos Hld (LDOS) reported outstanding financial performance in Q3 2024, with record margins and significant earnings growth. The company's strategic initiatives, including accelerated share repurchases and dividend increases, underscore its commitment to enhancing shareholder value. While challenges like future growth prospects and margin improvements exist, Leidos is well-positioned to leverage its strengths and capitalize on growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

RESTON, Va. , June 15, 2022 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, today announced the recipients of the 2022 Supplier Innovation & Technology awards.

Leidos Announces 2022 Supplier Innovation & Technology Award Winners

RESTON, Va. , May 31, 2022 /PRNewswire/ -- QTC Medical Services, Inc. (QTC), a Leidos (NYSE: LDOS) company, was recently awarded two prime contracts to provide medical disability examination services to both veterans and separating or retiring service members.

QTC Awarded $1.7 Billion Veteran and Service Member Medical Disability Exam Contracts

Live Audio Webcast Available on June 1, 2022, from 11:00 a.m. to 11:45 a.m.

Leidos to Participate in The Jefferies Virtual IT Services Summit 2022

Live Audio Webcast Available on June 1, 2022, from 2:30 p.m. to 3:20 p.m.

LEIDOS TO PARTICIPATE IN THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE

Leidos is a $14 billion defense stock benefiting from the geopolitical tensions along with the overall defense industry. The balance sheet needs some improvement, the valuation could be better, but the potential rewards outweigh the risks.

Leidos Holdings: IT In The Defense Industry

RESTON, Va. , May 6, 2022 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, has been awarded two internationally competed contracts by the NATO Communications and Information Agency (NCI Agency) to enhance the Alliance's ballistic missile defense (BMD) capabilities.

NATO Awards Leidos Ballistic Missile Defense Contracts

The defense contractor's first quarter wasn't a barn burner, but contract wins suggest that Leidos will soon grow strongly.

Here's Why Leidos Holdings Is Heading in the Right Direction

Alcoa

AbbVie

Bunge Global SA

Bristol-Myers

Chevron

DuPont de Nemours

Hess

Host Hotels & Resorts

McKesson

Vertex Pharmaceuticals

Most mutual funds have losses this year amid the market's sell-off. But JPMorgan Large Cap Value Fund is in positive territory.

Stocks That Lift This JPMorgan Fund In Down Market

Leidos Holdings' (LDOS) total revenues of $3,494 million in the quarter under consideration exceed the Zacks Consensus Estimate by 3.2% and also increase 5.4% year over year

Leidos Holdings (LDOS) Q1 Earnings Beat, Revenues Rise Y/Y

Leidos Holdings, Inc.'s (NYSE:LDOS ) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET Company Participants Roger Krone – Chairman and Chief Executive Officer Christopher Cage – Chief Financial Officer Stuart Davis – Investor Relations Conference Call Participants Peter Arment – Baird. Sheila Kahyaoglu – Jefferies.

Leidos Holdings, Inc.'s (LDOS) CEO Roger Krone on Q1 2022Results - Earnings Call Transcript

Leidos (LDOS) delivered earnings and revenue surprises of 6.04% and 3.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Leidos (LDOS) Surpasses Q1 Earnings and Revenue Estimates

Revenues of $3.5 billion, up 5% year-over-year Net Income of $177 million; Adjusted EBITDA of $358 million Diluted Earnings per Share of $1.25, or $1.58 on a non-GAAP basis Cash Flows from Operations of $93 million; Free Cash Flow of $65 million Net Bookings of $5.4 billion (book-to-bill ratio of 1.6) drive record backlog of $36.3 billion RESTON, Va., May 3, 2022 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS), a FORTUNE 500® science and technology leader, today reported financial results for the first quarter of fiscal year 2022.

Leidos Holdings, Inc. Reports First Quarter Fiscal Year 2022 Results

Live Audio Webcast Available on May 10, 2022 from 9:40 a.m. to 10:15 a.m.

LEIDOS TO PARTICIPATE IN THE GOLDMAN SACHS INDUSTRIALS AND MATERIALS CONFERENCE 2022

Leidos Holdings (LDOS) first-quarter results are likely to benefit from the ramp-up in contracts and impressive awards, partially offset by some program headwinds.

Will Program Headwinds Hurt Leidos' (LDOS) Q1 Earnings?

RESTON, Va. , April 27, 2022 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, held its groundbreaking ceremony recently to mark the start of construction for its new facility at the Campus Point location in San Diego, California.

Leidos Announces New San Diego Campus Point Facility

Leidos (LDOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Leidos (LDOS) to Report a Decline in Earnings: What to Look Out for

RESTON, Va. , April 7, 2022 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology leader, has scheduled a conference call for Tuesday, May 3, 2022, at 8 a.m.

Leidos Schedules First Quarter 2022 Earnings Conference Call for May 3, 2022 at 8 a.m. (ET)

RESTON, Va. , March 29, 2022 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, today announced the appointment of Steve Cook as Dynetics Group President, effective April 1.

Leidos Appoints Steve Cook to Lead Dynetics, Paul Engola as Deputy

Team Successfully Deploys Electronic Health Record to 14 Additional Commands RESTON, Va. , March 23, 2022 /PRNewswire/ -- The Leidos Partnership for Defense Health (LPDH) today announced it successfully delivered the MHS GENESIS electronic health record to an additional 15,000 clinicians and providers as part of its largest double Wave deployment to date, spanning 14 Military Treatment Facility Commands and five states.

Leidos Partnership Reaches 50% Deployment of MHS GENESIS System

Booz Allen Hamilton Hld

Jacobs Solutions Inc

Parsons Corp

Stifel on Friday resumed coverage of eight government services stocks and initiated coverage of KBR Inc. as the sector faces increased demand from an elevated threat environment.

The Ratings Game: Stifel relaunches defense stock coverage as Ukraine war rages

Leidos (LDOS) reported earnings 30 days ago. What's next for the stock?

Why Is Leidos (LDOS) Up 15% Since Last Earnings Report?

RESTON, Va. , March 17, 2022 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, today announced it has been awarded a prime contract by the U.S. Navy's Naval Information Warfare Systems Command (NAVWAR) to support the service's undersea warfare systems.

U.S. Navy Selects Leidos for Undersea Warfare Systems Contract

RESTON, Va., March 15, 2022 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, today announced it has been named one of the World's Most Ethical Companies ®.

Leidos Named to World's Most Ethical Companies® List for Fifth Consecutive Year

RESTON, Va., March 10, 2022 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology company, will participate in the J.P.

Leidos to Participate in the J.P. Morgan 2022 Industrials Conference

RESTON, Va., March 9, 2022 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, was recently awarded a new prime contract to provide biomedical preclinical and development capabilities to support the National Institute of Allergy and Infectious Diseases (NIAID).

News for Leidos Hld Stock (LDOS)